2. Search Result
Search Result
Results for "

urease inhibitor

" in MedChemExpress (MCE) Product Catalog:

36

Inhibitors & Agonists

3

Natural
Products

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W000932
    Butylboronic acid

    		Bacterial Infection
    Butylboronic acid is a competitive soybean urease inhibitor with an IC50 of 2.9 mM and a Ki of 1.5 mM .
    Butylboronic acid
  • HY-W278232
    Urease-IN-6

    		Bacterial Urease Infection
    Urease-IN-6 is a potent inhibitor of Urease with an IC50 of 14.2 μM. Urease-IN-6 can be used in study peptic and gastric ulcers .
    Urease-IN-6
  • HY-149775
    Urease-IN-10

    		Bacterial Urease Infection
    Urease-IN-10 (Conjugate 4) is a competitive Urease inhibitor, with an IC50 of 3.59±0.07 μM and a Ki of 7.45 μM. Urease-IN-10 is a conjugate consisting of Diclofenac (HY-15036) and Sulfanilamide (HY-B0242). Diclofenac-sulfanilamide inhibits the Jack bean urease(JBU) in a competitive manner .
    Urease-IN-10
  • HY-W357738
    Urease-IN-14

    		Bacterial Urease Infection
    Urease-IN-14 (compound 15) is an urease inhibitor and antioxidant. Urease-IN-14 shows DPPH radical scavenging and urease inhibitory activities with IC50 values 151.7 μM and 41.6 μM, respectively .
    Urease-IN-14
  • HY-155970
    Urease-IN-7

    		Bacterial Infection Inflammation/Immunology
    Urease-IN-7 (Compound 5k) is a competitive Urease inhibitor (IC50: 3.33 μM, Ki: 3.62 μM). Urease-IN-7 can be used for research of peptic and gastric ulcers .
    Urease-IN-7
  • HY-155973
    Urease-IN-8

    		Bacterial Infection Inflammation/Immunology
    Urease-IN-8 (Compound 5e) is a competitive Urease inhibitor (IC50: 3.51 μM, Ki: 3.11 μM). Urease-IN-8 can be used for research of peptic and gastric ulcers .
    Urease-IN-8
  • HY-115939
    Urease-IN-2

    		Bacterial Urease Infection
    Urease-IN-2 (compound 8g) is a non-competitive urease inhibitor with an IC50 of 0.94 μM and a Ki of 1.6 μM. Urease-IN-2 inhibits the Jack bean urease (JBU) in a non-competitive manner .
    Urease-IN-2
  • HY-W237498
    Urease-IN-17

    		Bacterial Infection Inflammation/Immunology
    Urease-IN-17 (9) is a urease inhibitor, with an IC50 of 84 μM .
    Urease-IN-17
  • HY-162139
    Urease-IN-11

    		Bacterial Inflammation/Immunology
    Urease-IN-11 (Compound 6e) is a competitive urease inhibitor (IC50)=10.41 µM). Urease-IN-11 can be used to study diseases such as urease-related gastritis and peptic ulcer .
    Urease-IN-11
  • HY-147787
    Urease-IN-3

    		Bacterial Urease Infection
    Urease-IN-3 (Compound L12) is a potent inhibitor of Urease with an IC50 of 1.449 μM. Urease-IN-3 is a flavonoid analogue compound .
    Urease-IN-3
  • HY-141806
    Urease-IN-1

    		Bacterial Infection
    Urease-IN-1 is an urease inhibitor with an IC50 value of 2.21 ± 0.45 µM.
    Urease-IN-1
  • HY-163404
    Urease-IN-13

    		Bacterial Infection Inflammation/Immunology
    Urease-IN-13 (compound d8) is an inhibitor of urease with an IC50 value of 1.21 μM. Urease-IN-13 can be used in the study of infectious gastritis and gastric ulcer .
    Urease-IN-13
  • HY-168434
    Urease-IN-19

    		Urease Metabolic Disease
    Urease-IN-19 (Compound 3c) is a potent urease inhibitor with an IC50 value of 2.7 µM. Urease-IN-19 is promising for research of kidney stones and stomach ulcers .
    Urease-IN-19
  • HY-156369
    Urease-IN-9

    		Bacterial Infection
    Urease-IN-9 (Compound 1e) is an urease inhibitor (IC50: 19.5?μM) .
    Urease-IN-9
  • HY-170608
    Urease-IN-18

    		Bacterial Infection
    Urease-IN-18 (compound 13a) is an uncompetitive urease inhibitor with an IC50 value of 1.6 μM. Urease helps maintain an alkaline environment favorable for the survival and proliferation of specific pathogens within the host .
    Urease-IN-18
  • HY-152669
    Urease-IN-5

    		Bacterial Infection
    Urease-IN-5 is an inhibitor of urease with an IC50 value of 1.473 µM. Urease-IN-5 has low cytotoxicity and inhibitory activity on P. vulgaris with an IC50 value of 17.78 µg/mL .
    Urease-IN-5
  • HY-161761
    Urease-IN-15

    		Bacterial Infection
    Urease-IN-15 (compound 5g) is an uncompetitive inhibitor of urease in manner with the IC50 of 3.80 µM .
    Urease-IN-15
  • HY-170937
    Urease-IN-20

    		Bacterial Apoptosis Reactive Oxygen Species (ROS) Infection
    Urease-IN-20 (compound XBP2) is an inhibitor of Helicobacter pylori (H. pylori). Urease-IN-20 inhibits H. pylori with an IC50 of 0.14 μM. Urease-IN-20 reduces cell Apoptosis and decreases ROS and γH2AX in GES-1 cells infected with H. pylori. Urease-IN-20 exhibits significant gastric mucosal protective effects. Urease-IN-20 shows the potential for H. pylori research .
    Urease-IN-20
  • HY-161998
    Urease-IN-16

    		Bacterial Urease Others
    Urease-IN-16 (compound 4e) is a urease inhibitor, with an IC50 value of 132 μmol/L. Urease-IN-16 can coordinate with the nickel atom through the oxygen atoms of carbonyl or boronic acid groups. Urease-IN-16 shows great potential as an additive in the development of efficient fertilizers and medical applications .
    Urease-IN-16
  • HY-152668
    Urease-IN-4

    		Bacterial Infection
    Urease-IN-4 is an effective inhibitor of urease with an IC50 value of 1.64 µM. Urease-IN-4 has low cytotoxicity and shows inhibitory activity on P. vulgaris with an IC50 value of 15.27 µg/mL .
    Urease-IN-4
  • HY-162149
    Urease-IN-12

    		Bacterial Infection
    Urease-IN-12 (compound 5e) is a competitive urease inhibitor (IC50: 0.35 μM) with the potential to inhibit gastritis and peptic ulcer caused by Helicobacter pylori .
    Urease-IN-12
  • HY-N9746
    (R)-4-Methoxydalbergione

    		Parasite Infection
    (R)-4-Methoxydalbergione is a urease inhibitor with IC50s of 59.72 and 67.33 μM for Bacillus pasteurii urease and Jack bean urease. (R)-4-Methoxydalbergione also has antiplasmodial activity. (R)-4-Methoxydalbergione can be isolated from Ranunculus repens .
    (R)-4-Methoxydalbergione
  • HY-W012824
    4-Amino-m-cresol

    		Biochemical Assay Reagents Others
    4-Amino-m-cresol inhibits soil urease activity .
    4-Amino-m-cresol
  • HY-107792
    Benurestat

    		Bacterial Infection
    Benurestat is an orally active urease inhibitor. Benurestat can be used for infected ureolysis research .
    Benurestat
  • HY-100956
    Flurofamide

    		Bacterial Infection
    Flurofamide is a potent bacterial urease inhibitor with potential in the treatment of infection induced urinary stones .
    Flurofamide
  • HY-W090317
    2,5-Dimethyl-1,4-benzoquinone

    DMBQ; 2,5-Dimethyl-p-quinone; Phlorone

    		 Urease Others
    2,5-Dimethyl-1,4-benzoquinone is a jack bean urease (HY-P2767) inhibitor (IC50: 0.98 μM). 2,5-Dimethyl-1,4-benzoquinone can be used in the study of soil urease activity in agriculture .
    2,5-Dimethyl-1,4-benzoquinone
  • HY-107199
    N-Butylthiophosphoric triamide

    NBPT

    		 Urease Others
    N-Butylthiophosphoric triamide (NBPT) is a potent urease inhibitor. Butylthiophosphoric triamide inhibits nitrification and reduces the conversion of urea to NH3 gas .
    N-Butylthiophosphoric triamide
  • HY-N2224
    Guaijaverin

    		Bacterial Infection
    Guaijaverin is a urease inhibitor with an IC50 of 120 μM. Guaijaverin shows antioxidant and anti-Streptococcus mutans activities .
    Guaijaverin
  • HY-155521
    Enzyme-IN-2

    		Bacterial Infection
    Enzyme-IN-2 (compound 15) is a ureases inhibitor (Ki=2.36 μM) with anti-ureolytic activity (IC50=0.75 μM) .
    Enzyme-IN-2
  • HY-W013007
    4-Hexen-3-one

    2-Hexen-4-one

    		 Endogenous Metabolite Bacterial Infection Inflammation/Immunology
    4-Hexen-3-one inhibits the growth of H. pylori strain ATCC 43526 and TDR H. pylori strains. 4-Hexen-3-one inhibits urease activities .
    4-Hexen-3-one
  • HY-N2224R
    Guaijaverin (Standard)

    		Bacterial Infection
    Guaijaverin (Standard) is the analytical standard of Guaijaverin. This product is intended for research and analytical applications. Guaijaverin is a urease inhibitor with an IC50 of 120 μM. Guaijaverin shows antioxidant and anti-Streptococcus mutans activities .
    Guaijaverin (Standard)
  • HY-B1235
    Acetohydroxamic acid
    1 Publications Verification

    N-Hydroxyacetamide

    		 Bacterial HIV Infection Inflammation/Immunology
    Acetohydroxamic acid is the inhibitor for bacterial and plant urease that can be used for chronic urinary tract infections. Acetohydroxamic acid selectively inhibits arachidonic acid 5-lipoxygenase that is useful in the research of asthma. Acetohydroxamic acid inhibits the formation of advanced glycation end products, and reduces oxidative stress and inflammatory responses. Acetohydroxamic acid exhibits antiviral activity against HIV .
    Acetohydroxamic acid
  • HY-W176199
    DPPD-Q

    		Reactive Oxygen Species (ROS) Metabolic Disease
    DPPD-Q is an oxidized derivative of the antioxidant and substituted p-phenylenediamine DPPD, which is found in tire wear particles and crumb rubber, particulate matter 2.5 (PM2.5), and wastewater influent and effluent. DPPD-Q inhibits jack bean urease by 91.4% at 5 µM .
    DPPD-Q
  • HY-B1235R
    Acetohydroxamic acid (Standard)

    N-Hydroxyacetamide (Standard)

    		 Bacterial HIV Infection Inflammation/Immunology
    Acetohydroxamic acid (Standard) is the analytical standard of Acetohydroxamic acid. This product is intended for research and analytical applications. Acetohydroxamic acid is the inhibitor for bacterial and plant urease that can be used for chronic urinary tract infections. Acetohydroxamic acid selectively inhibits arachidonic acid 5-lipoxygenase that is useful in the research of asthma. Acetohydroxamic acid inhibits the formation of advanced glycation end products, and reduces oxidative stress and inflammatory responses. Acetohydroxamic acid exhibits antiviral activity against HIV .
    Acetohydroxamic acid (Standard)
  • HY-161860
    Antibacterial agent 233

    		Bacterial Cancer
    Antibacterial agent 233 (Compound 7c) exhibits inhibitory efficacy against Helicobacter pylori with MIC of 0.4-1.6 μg/mL. Antibacterial agent 233 inhibits jack bean urease (IC50 is 0.27 μg/mL), changes the permeability of H. pylori cell membrane, causes the leakage of cellular contents. Antibacterial agent 233 exhibits metabolic stability in whole blood and artificial gastric fluid. Antibacterial agent 233 exhibits antitumor efficacy against U2OS in mice .
    Antibacterial agent 233
  • HY-173428
    Antifungal agent 130

    		Fungal Infection
    Antifungal agent 130 (Compound A7) is an orally active antifungal agent. Antifungal agent 130 has good antifungal activity against Candida albicans (MIC = 0.12 ng/mL) and Cryptococcus neoformans (MIC = 0.12 ng/mL) and has excellent antivirulence effect. Antifungal agent 130 exerts its antifungal effect by disrupting the iron homeostasis of fungal cells and inducing oxidative stress damage. Antifungal agent 130 can inhibit the formation of fungal virulence factors (such as biofilm, capsule, urease and melanin). Antifungal agent 130 has good antifungal effect and can be used in the study of drug-resistant fungal infections .
    Antifungal agent 130

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: